14. Weidinger S., Klopp N., Wagenpfeil S., et al. Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults // J. Med. Genet. - 2004. - Vol.41. - P.658-663.
Лечебные "стратегии будущего"
1. Barnes P.J. Cytokine modulators as novel therapies for airway disease // Eur. Respir. J. - 2001. - V.18. - suppl.34 - P.67s-77s.
2. Caramory G., Groneberg D., Ito K., Casolari P.Adcock I.M., Papi A. New drugs targeting Th2 lymphocytes in asthma // J. of Occupational Medicine and Toxicology. - 2008. - V.3. (Suppl 1):S6.
3. Losman J.A., Chen X.P., Hilton D., Rothman P. Cutting edge: Socs-1 is a potent inhibitor of ИЛ-4 signal transduction // J. Immunol. - 1999. - V.162. - P.3770-3774.
4. O'Shea J. J. Targeting the Jak/STAT pathway for immunosuppression // Ann. Rheum. Dis. - 2004. - Vol. 63 (Suppl. II) - Р. ii67-ii71.
5. O'Shea J. J., Park H., Pesu M., Borie D., Changelian P. New strategies for immunosuppression: interfering with cytokines by targeting the JAK/STAT pathway // Curr. Opin. Rheumatol. - 2005. - Vol. 17, № 3. - P. 305-311.
6. Schindler C.W. JAK-STAT signaling in human disease // J. Clin. Invest. - 2002. - Vol. 109. - P. 1133-1137.
7. Turkson J., Kim J.S., Zhang S., Yuan J., Huang M., Glenn M. et al. Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity // Mol. Cancer Ther. - 2004. - Vol. 3 - Р.261-269.
8. Zhang J.G. et al. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation // Proc. Natl. Acad. Sci. USA. - 1999. - V.96. - P.2071-2076.